Form 4: Vigil Neuroscience CFO Jennifer Ziolkowski Reports Stock Option Award

Jennifer Lynn Ziolkowski, CFO of Vigil Neuroscience, reports the acquisition of a stock option award for 156,000 shares.

Summary

• Jennifer Lynn Ziolkowski, the Chief Financial Officer of Vigil Neuroscience, Inc. (VIGL), filed a Form 4 on March 4, 2025.
• The report details a transaction on March 3, 2025, where Ziolkowski acquired a stock option award for 156,000 shares of common stock.
• The exercise price of the stock options is $2.19.
• The options vest in 48 equal monthly installments, starting on April 3, 2025, and expire on March 3, 2035.
• The stock option award was issued pursuant to the Issuer's 2021 Stock Option and Incentive Plan.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to a key executive. It's generally positive as it incentivizes the CFO, but it's not a major event.

Positives

• The granting of stock options to the CFO aligns her interests with those of the shareholders, incentivizing her to improve the company's performance.
• The vesting schedule encourages long-term commitment from the CFO.

Industry Context

Stock option awards are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• Vesting schedules, such as the 48-month monthly vesting in this case, are typical to ensure executive retention and alignment with long-term company goals.
• The size of the grant (156,000 shares) would need to be compared to grants made to CFOs at peer companies of similar market capitalization and stage of development to assess its relative magnitude.

Stakeholder Impact

• Shareholders may view the stock option award positively as it aligns the CFO's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates